Sort
130,381 grants matching “hiv”
Fogarty AIDS International Training &Research Program *
$1,350,000Johns Hopkins University · D43 · FY2005 · TW
GH11-1191 IMPROVEMENT OF INTERGRATED HIV CLINICAL-BASED SERVICES
$1,350,000Scott Barnhart · University Of Washington · U2G · FY2012 · GH
Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC) Substudy: Hearing Sensitivity Characteristics in AMP Up Young Adults.
$1,350,000George R Seage · Harvard School Of Public Health · U01 · FY2016 · HD
UCSF Prevention Research Center
$1,349,604Marguerita A Lightfoot · University Of California, San Francisco · U48 · FY2021 · DP
National Center on Minority Health and Health Disparities-Center
$1,349,435Jerome Frank Strauss · Virginia Commonwealth University · P60 · FY2011 · MD
Risk Factors for Aged Related Bone Loss
$1,349,412Douglas P. Kiel · Hebrew Rehabilitation Center For Aged · R01 · FY2007 · AR
Oral Carcinogenesis
$1,349,334J. Silvio Gutkind · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
Natural History of HIV Infection in Injection Drug Users
$1,349,113Gregory D Kirk · Johns Hopkins University · R37 · FY2006 · DA
A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
$1,348,882David M. Margolis · Univ Of North Carolina Chapel Hill · U01 · FY2016 · AI
A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
$1,348,882David M. Margolis · Univ Of North Carolina Chapel Hill · U01 · FY2018 · AI
University of Washington Center for Aids Research
$1,348,837University Of Washington · P30 · FY2004 · AI
Molecular Interactions of HIV-1 with the Nuclear Pore Complex
$1,348,805Gregory B Melikian · Emory University · R01 · FY2022 · AI
Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV
$1,348,648Pietro P Sanna · Scripps Research Institute, The · U01 · FY2023 · DA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$1,348,462Kenner Rice · National Institute On Drug Abuse · ZIA · FY2017 · DA
Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV
$1,348,437Pietro P Sanna · Scripps Research Institute, The · U01 · FY2025 · DA
Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV
$1,348,437Pietro P Sanna · Scripps Research Institute, The · U01 · FY2024 · DA
Infections, immunity, and inflammation in cancer
$1,348,235Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle
$1,348,086Thomas Hope · Northwestern University At Chicago · R01 · FY2024 · AI
SUPPORT OF TRAINING OF HIV HEALTH CARE PROVIDERS IN THE REPUBLIC OF BOTSWANA UNDE
$1,347,938Tendani Gaolathe · Botswana-Harvard Aids Institute · U2G · FY2012 · PS
EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION
$1,347,763Marx Preston · Tulane University Of Louisiana · N01 · FY2016 · AI
Epitope-focused vaccine strategies against Zika virus
$1,347,756Michel C Nussenzweig · Rockefeller University · P01 · FY2020 · AI
Epitope-focused vaccine strategies against Zika virus
$1,347,756Michel C Nussenzweig · Rockefeller University · P01 · FY2019 · AI
Epitope-focused vaccine strategies against Zika virus
$1,347,756Michel C Nussenzweig · Rockefeller University · P01 · FY2022 · AI
Epitope-focused vaccine strategies against Zika virus
$1,347,756Michel C Nussenzweig · Rockefeller University · P01 · FY2021 · AI
Drug-resistance testing in Kenya to improve ART suppression of HIV replication
$1,347,525Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2014 · AI